MX342938B - Composicion farmaceutica de fosfomicina. - Google Patents

Composicion farmaceutica de fosfomicina.

Info

Publication number
MX342938B
MX342938B MX2013007232A MX2013007232A MX342938B MX 342938 B MX342938 B MX 342938B MX 2013007232 A MX2013007232 A MX 2013007232A MX 2013007232 A MX2013007232 A MX 2013007232A MX 342938 B MX342938 B MX 342938B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
phosphomycin
present
composition
phosphomycin pharmaceutical
Prior art date
Application number
MX2013007232A
Other languages
English (en)
Other versions
MX2013007232A (es
Inventor
Darder Carlos Picornell
Original Assignee
Arafarma Group S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arafarma Group S A filed Critical Arafarma Group S A
Publication of MX2013007232A publication Critical patent/MX2013007232A/es
Publication of MX342938B publication Critical patent/MX342938B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica sólida de fosfomicina estable frente a la coloración, apta para diabéticos y que no causa problemas gastrointestinales. La composición farmacéutica de esta invención comprende fosfomicina trometamol, glicina, y opcionalmente otros excipientes como sucralosa, dióxido de silicio, polivinilpirrolidona y aroma; y está sustancialmente libre de azúcares y alcoholes de azúcar tales como sacarosa, fructosa, glucosa, xilitol, manitol, sorbitol o mezclas de éstos.
MX2013007232A 2010-12-24 2011-12-19 Composicion farmaceutica de fosfomicina. MX342938B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201001613A ES2385158B1 (es) 2010-12-24 2010-12-24 Composición farmacéutica de fosfomicina
PCT/ES2011/000366 WO2012085304A1 (es) 2010-12-24 2011-12-19 Composición farmacéutica de fosfomicina

Publications (2)

Publication Number Publication Date
MX2013007232A MX2013007232A (es) 2013-08-15
MX342938B true MX342938B (es) 2016-10-19

Family

ID=46313210

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007232A MX342938B (es) 2010-12-24 2011-12-19 Composicion farmaceutica de fosfomicina.

Country Status (15)

Country Link
EP (1) EP2656846B1 (es)
JP (1) JP6012622B2 (es)
KR (1) KR20140091649A (es)
CN (1) CN103282038B (es)
BR (1) BR112013016029A2 (es)
CA (1) CA2821382C (es)
DK (1) DK2656846T3 (es)
EA (1) EA023846B1 (es)
ES (2) ES2385158B1 (es)
HK (1) HK1188959A1 (es)
HU (1) HUE027572T2 (es)
MX (1) MX342938B (es)
PL (1) PL2656846T3 (es)
PT (1) PT2656846T (es)
WO (1) WO2012085304A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017111718A1 (en) 2015-12-25 2017-06-29 Yusuf Toktamiş Öğün The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1231013B (it) 1989-07-27 1991-11-08 Zambon Spa Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
ES2103682B1 (es) * 1995-09-20 1998-04-01 Lilly Sa Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas.
ITMI20021725A1 (it) * 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
ES2244333B1 (es) * 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.

Also Published As

Publication number Publication date
EP2656846A4 (en) 2014-07-09
CA2821382A1 (en) 2012-06-28
PT2656846T (pt) 2016-07-08
ES2574916T3 (es) 2016-06-23
CN103282038A (zh) 2013-09-04
EP2656846A1 (en) 2013-10-30
EA201390760A1 (ru) 2013-12-30
JP6012622B2 (ja) 2016-10-25
ES2385158A1 (es) 2012-07-19
HK1188959A1 (zh) 2014-05-23
JP2014500301A (ja) 2014-01-09
ES2385158B1 (es) 2013-05-28
CA2821382C (en) 2019-01-08
KR20140091649A (ko) 2014-07-22
EA023846B1 (ru) 2016-07-29
EP2656846B1 (en) 2016-03-30
PL2656846T3 (pl) 2016-09-30
HUE027572T2 (en) 2016-10-28
BR112013016029A2 (pt) 2017-06-13
CN103282038B (zh) 2016-08-10
WO2012085304A1 (es) 2012-06-28
DK2656846T3 (en) 2016-07-04
MX2013007232A (es) 2013-08-15

Similar Documents

Publication Publication Date Title
ES2527654T3 (es) Barquillo
MX2012002749A (es) Aumentadores de dulzura incluyendo rebaudiosido a o d.
NZ603332A (en) Sweet flavor modifier
BR112012028618A2 (pt) composição edulcorantes com reduzido sabor desagradável amargo e métodos de preparo
MX2016007178A (es) Glucosidos de triterpeno novedosos como edulcorantes o potenciadores de edulcorantes.
WO2013039365A3 (ko) 지소화성 성분을 함유하는 당뇨 개선용 감미 소재 조성물
WO2009102820A3 (en) Modified sugar substrates and methods of use
PE20121517A1 (es) Compuestos lipopeptidos y metodos relacionados
WO2011124953A3 (en) Controlled release pharmaceutical compositions of tapentadol
AR051048A1 (es) Sustituto del azucar bajo en calorias o sin calorias, no higroscopico
BR112012021771A2 (pt) métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2.
WO2014207770A3 (en) A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same
PH12016500662A1 (en) Reduced sugar frozen confection composition
WO2006120574A3 (en) Analogs of 4-hydroxyisoleucine and uses thereof
WO2012098522A3 (en) Detergent composition including a saccharide or sugar alcohol
UA112974C2 (uk) Нікотиновмісна композиція (варіанти)
WO2016186338A8 (ko) 감미질 및 결정화가 개선된 사이코스 혼합당 조성물
WO2013039364A3 (ko) 당 분해 억제성 성분을 함유하는 비만 예방 및 개선용 감미 소재 조성물
MX2013007232A (es) Composicion farmaceutica de fosfomicina.
WO2011025978A3 (en) Methods of treatment using anti-oxidized ldl antibodies
BR112012010182A2 (pt) Composição de mistura de café de baixa caloria preparada mediante o uso de d-tagatose.
ATE534382T1 (de) Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
CL2009001005A1 (es) Compuestos derivados de butirato de trimetilamonio, inhibidores de cpt2; proceso de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento o prevencion de enfermedades tales como hiperglucemia, diabetes, hipertension, entre otras patologias.
AR086794A1 (es) Composicion farmaceutica de fosfomicina
GR1007432B (el) Σιροπι με γευση κακαο, χωρις σακχαρα, με χαμηλο γλυκαιμικο δεικτη, με φυτικες ινες

Legal Events

Date Code Title Description
FG Grant or registration